Romosozumab-Aqqg
Evenity
NADAC/unit
N/A
No Shortage
Tier 1: 0.9%
PA Req: 6.1%
Market Intelligence
2025-07-30 Class II Recall: Mckesson Medical-Surgical Inc. Corporate Office
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
